300595 (Autek China Inc) vs Shanghai Composite Comparison

300595

Shanghai Composite

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

300595

Shanghai Composite

Difference

1Y 3Y 5Y 10Y 15Y 20Y

300595

Shanghai Composite

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Composite

300595

7741

ALC

COLO B

ALGN

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Autek China Inc
Glance View

Market Cap

15.4B CNY

Industry

Health Care

Autek China Inc. stands as an emblematic figure in the dynamic landscape of medical devices and biotechnology in China. Rooted in its mission to innovate within the realms of diagnostic imaging and therapeutic ultrasound equipment, the company has maneuvered through this niche market by leveraging both cutting-edge technology and strategic partnerships. Autek's portfolio includes a range of high-quality ultrasound machines and imaging solutions that cater to the rapidly evolving needs of hospitals and clinics. By capitalizing on the growing demand for advanced healthcare services in China, Autek has tailored its product offerings to resonate with local market needs while maintaining competitive pricing strategies. This keen understanding of market dynamics allows Autek to maintain a robust sales pipeline and forge sturdy relationships within the medical community, driving its revenue growth engine. The company's operational blueprint hinges on an impressive blend of research-driven innovation and effective distribution networks. Autek continually invests in research and development, aspiring to push technological boundaries and uphold its reputation as a pioneer in the medical imaging sector. This investment lays the groundwork for creating state-of-the-art products that are not only technologically advanced but also user-friendly for medical professionals. Autek's adeptness at navigating regulatory landscapes ensures smooth market entry and expansion for its offerings. Furthermore, its strategic alliances with healthcare providers and government entities enhance its distribution network, ensuring that its products reach a wide spectrum of healthcare institutions across China. Autek makes its money by selling its technologically advanced and reliable devices, as well as providing ongoing support and maintenance services, forming the backbone of its revenue model and securing its position in the competitive arena.

View Autek China Inc Analysis

Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

JP		Hoya Corp TSE:7741	Add
CH		Alcon AG SIX:ALC	Add
DK		Coloplast A/S CSE:COLO B	Add
US		Align Technology Inc NASDAQ:ALGN	Add
KR	H	HLB Inc KOSDAQ:028300	Add
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	Add
US		Lantheus Holdings Inc NASDAQ:LNTH	Add
CA		Bausch + Lomb Corp NYSE:BLCO	Add
UK		ConvaTec Group PLC LSE:CTEC	Add
US		Merit Medical Systems Inc NASDAQ:MMSI	Add

JP		Hoya Corp TSE:7741	Select
CH		Alcon AG SIX:ALC	Select
DK		Coloplast A/S CSE:COLO B	Select
US		Align Technology Inc NASDAQ:ALGN	Select
KR	H	HLB Inc KOSDAQ:028300	Select
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	Select
US		Lantheus Holdings Inc NASDAQ:LNTH	Select
CA		Bausch + Lomb Corp NYSE:BLCO	Select
UK		ConvaTec Group PLC LSE:CTEC	Select
US		Merit Medical Systems Inc NASDAQ:MMSI	Select

JP		Hoya Corp TSE:7741	Add
CH		Alcon AG SIX:ALC	Add
DK		Coloplast A/S CSE:COLO B	Add
US		Align Technology Inc NASDAQ:ALGN	Add
KR	H	HLB Inc KOSDAQ:028300	Add
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	Add
US		Lantheus Holdings Inc NASDAQ:LNTH	Add
CA		Bausch + Lomb Corp NYSE:BLCO	Add
UK		ConvaTec Group PLC LSE:CTEC	Add
US		Merit Medical Systems Inc NASDAQ:MMSI	Add

CA	A	Advance Lithium Corp XTSX:AALI	Add
US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

	Franklin Covey Co NYSE:FC	35.24 USD -2.49%
	Mohawk Industries Inc NYSE:MHK	117.3 USD -0.4%
	Ardmore Shipping Corp NYSE:ASC	12.77 USD 5.54%
	ASGN Inc NYSE:ASGN	86.34 USD 1.25%
	Skyworks Solutions Inc NASDAQ:SWKS	92.66 USD 1.93%
	Weatherford International PLC NASDAQ:WFRD	74.8 USD 1.75%

300595

vs

Shanghai Composite

Stocks Performance
300595 vs Shanghai Composite

Performance Gap
300595 vs Shanghai Composite

Performance By Year
300595 vs Shanghai Composite

Competitors Performance
Autek China Inc vs Peers

Autek China Inc
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	146.23 USD 1.79%
	Bank of America Corp NYSE:BAC	46.08 USD 1.5%
	Mastercard Inc NYSE:MA	511.4 USD -0.1%
	Salesforce Inc NYSE:CRM	324.93 USD -1.69%
	Abbvie Inc NYSE:ABBV	179.53 USD -0.32%
	Home Depot Inc NYSE:HD	384.23 USD -1.32%

	Arista Networks Inc NYSE:ANET	115.29 USD -3.1%
	Visa Inc NYSE:V	311.67 USD -0.44%
	Texas Pacific Land Corp NYSE:TPL	1 258.29 USD 2.58%
	KLA Corp NASDAQ:KLAC	689.3 USD -0.14%
	Manhattan Associates Inc NASDAQ:MANH	268.2 USD -1.16%
	Pinduoduo Inc NASDAQ:PDD	100.62 USD 1.62%

	Salesforce Inc NYSE:CRM	324.93 USD -1.69%
	ServiceNow Inc NYSE:NOW	1 054.15 USD -2.13%
	EOG Resources Inc NYSE:EOG	127.56 USD 0.93%
	Copart Inc NASDAQ:CPRT	56.24 USD -0.6%
	Applied Materials Inc NASDAQ:AMAT	177.82 USD 0.19%
	Synopsys Inc NASDAQ:SNPS	487.62 USD -2.68%

	Johnson & Johnson NYSE:JNJ	146.23 USD 1.79%
	Berkshire Hathaway Inc NYSE:BRK.A	678 560 USD 0.29%
	Bank of America Corp NYSE:BAC	46.08 USD 1.5%
	Mastercard Inc NYSE:MA	511.4 USD -0.1%
	UnitedHealth Group Inc NYSE:UNH	514.25 USD 0.11%
	Exxon Mobil Corp NYSE:XOM	108.75 USD 0.94%

300595 vs Shanghai Composite

Stocks Performance 300595 vs Shanghai Composite

Performance Gap 300595 vs Shanghai Composite

Performance By Year 300595 vs Shanghai Composite

Competitors Performance Autek China Inc vs Peers

Autek China Inc Glance View

Company

Help

Tools

Stocks

300595

vs

Shanghai Composite

Stocks Performance
300595 vs Shanghai Composite

Performance Gap
300595 vs Shanghai Composite

Performance By Year
300595 vs Shanghai Composite

Competitors Performance
Autek China Inc vs Peers

Autek China Inc
Glance View